Advertisement

Liver Cancer Medications

Here's a list of the approved drugs to treat liver cancer. Click on any of the medications for more info on indications, dosing and side effects.


Quick Filter

*generic version available

E experimental

DRUG Chemotherapy
GENERIC NAME Multiple
DRUG RECOMMENDATION

Cytotoxic chemotherapy, the oldest and most commonly used type of cancer treatment, halts cell division and kills rapidly growing cells. For a full list of chemotherapy drugs, click here.

DRUG Keytruda
GENERIC NAME pembrolizumab
DRUG RECOMMENDATION

Keytruda is a PD-1 checkpoint inhibitor approved for advanced melanoma, non-small-cell lung cancer, bladder (urothelial) cancer, head and neck cancer, liver cancer, relapsed or refractory classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, Merkel cell carcinoma and for all metastatic solid tumors with high microsatellite instability or mismatch repair deficiency genetic mutations.

DRUG Opdivo
GENERIC NAME nivolumab
DRUG RECOMMENDATION

Opdivo is a checkpoint inhibitor approved for advanced or metastatic melanoma, metastatic non-small-cell lung cancer, advanced kidney cancer, relapsed or refractory classical Hodgkin lymphoma, recurrent or metastatic head and neck cancer, metastatic bladder (urothelial) cancer, liver cancer and colorectal cancer with high microsatellite instability or mismatch repair deficiency genetic mutations.

DRUG Cabometyx
GENERIC NAME cabozantinib
DRUG RECOMMENDATION

Cabometyx is a multikinase inhibitor approved for advanced kidney cancer (renal cell carcinoma) and previously treated liver cancer (hepatocellular carcinoma).

DRUG Lenvima
GENERIC NAME lenvatinib
DRUG RECOMMENDATION

Lenvima is a multikinase inhibitor approved for treatment of recurrent or metastatic thyroid cancer, previously treated kidney cancer and inoperable liver cancer.

DRUG Nexavar
GENERIC NAME sorafenib
DRUG RECOMMENDATION

Nexavar is a multikinase inhibitor approved for treatment of inoperable liver cancer that can't be surgically removed, advanced kidney cancer and recurrent or metastatic thyroid cancer.

DRUG Stivarga
GENERIC NAME regorafenib
DRUG RECOMMENDATION

Stivarga is a multikinase inhibitor approved for metastatic colorectal cancer, advanced or metastatic gastrointestinal stromal tumors (GIST) and liver cancer previously treated with Nexavar (sorafenib).

DRUG Vitrakvi
GENERIC NAME larotrectinib
DRUG RECOMMENDATION

Vitrakvi is a tropomyosin receptor kinase (TRK) inhibitor that works against cancers anywhere in the body with NTRK gene fusions.

Advertisement

Hot topics